Devon Charlton

Devon Charlton practices at UPMC Regional Orthopaedics in New Castle, Pennsylvania.

Devon Charlton's NPI, 1215203443, was assigned on April 2, 2012. Devon Charlton holds Pennsylvania license MD460646.

Devon Charlton's primary practice is UPMC Regional Orthopaedics, at 3120 Wilmington Rd, New Castle, PA 16105 in Lawrence County. The practice phone is (724) 658-5311.

Devon Charlton's primary practice is UPMC Regional Orthopaedics in New Castle, Pennsylvania. Devon Charlton is also affiliated with UPMC Jameson. The medical group on file is Stull, Jarvis, and Spinola Internal Medicine Associates-UPMC. Dmand AI also links Devon Charlton to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Devon Charlton practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Devon Charlton's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Devon Charlton is licensed in Pennsylvania.

CMS data shows 1,354 Medicare services from Devon Charlton across 8 procedure codes in 2024, for 195 Medicare patients. Medicare paid $46,471 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Devon Charlton in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have arthritis, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Devon Charlton's median patient age at 68, with 70% women.

In 2024, Devon Charlton wrote 2,080 Medicare Part D claims for 436 patients. 82% of them were for generic drugs. CMS names the drug for 1,932 of them, across 37 drugs with 11 or more claims each, at $1,710,320 in total drug cost. In 2023, CMS named 1,863 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Devon Charlton for performance year 2024, reported as part of a group. Devon Charlton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Devon Charlton as offering telehealth.

Dmand AI links 3 papers to Devon Charlton, published from 2018 to 2022. Devon Charlton's most frequent co-authors are Rohit Aggarwal, MD, Robyn T. Domsic and Siamak Moghadam-Kia, MD, MPH.

CMS Open Payments shows 308 general payments to Devon Charlton from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Abbvie Inc. paid the most, $78,108.